References

Ashman, J.B. and J. Miller, 1999. A role for the transmembrane domain in the trimerization of the MHC class II-associated invariant chain. J. Immunol., 163: 2704-2712.
Direct Link  |  

Chen, F., F. Meng, L. Pan, F. Xu, X. Liu and W. Yu, 2012. Boosting immune response with the invariant chain segments via association with non-peptide binding region of major histocompatibility complex class II molecules. BMC Immunol., Vol. 13. 10.1186/1471-2172-13-55

Hashish, E.A., C. Zhang, X. Ruan, D.E. Knudsen and C.C. Chase et al., 2013. A multiepitope fusion antigen elicits neutralizing antibodies against enterotoxigenic escherichia coli and homologous bovine viral diarrhea virus in vitro. Clin. Vaccine Immunol., 20: 1076-1083.
CrossRef  |  

Heine, H.G., M. Haritou, P. Failla, K. Fahey and A. Azad, 1991. Sequence analysis and expression of the host-protective immunogen VP2 of a variant strain of infectious bursal disease virus which can circumvent vaccination with standard type I strains. J. Gen. Virol., 72: 1835-1843.

Huang, X., W.Y. Yu and D.L. Zhong, 2003. Prediction of latent antigenic epitopes for NDV F48E9 and LaSota HN structure protein. Anhui Agri. Sci. Bull., 14: 101-103 (In Chinese).

Jasanoff, A., G. Wagner and D.C. Wiley, 1998. Structure of a trimeric domain of the MHC class II-associated chaperonin and targeting protein Ii. EMBO J., 17: 6812-6818.
CrossRef  |  

Li, W., Q. Chen, Q. Lin, Y. Lv and J. Feng et al., 2013. Immunogenicity of a multiepitope plasmid DNA encoding T and B lymphocyte epitopes from latent membrane protein 2 (LMP2) of epstein-barr virus as a vaccine in mice. Protein Peptide Lett., 20: 1136-1143.
Direct Link  |  

Lindner, R., 2002. Transient surface delivery of invariant chain‐MHC II complexes via endosomes: A quantitative study. Traffic, 3: 133-146.
CrossRef  |  

Pradhan, S.N., P.R. Prince, J. Madhumathi, P. Roy, R.B. Narayanan and U. Antony, 2012. Protective immune responses of recombinant VP2 subunit antigen of infectious bursal disease virus in chickens. Vet. Immunol. Immunopathol., 148: 293-301.
CrossRef  |  

Roche, P.A. and P. Cresswell, 2011. Proteolysis of the class II-associated invariant chain generates a peptide binding site in intracellular HLA-DR molecules. Proc. Natl. Acad. Sci. USA. 1991. 88: 3150-3154. J. Immunol., 187: 1076-1080.
PubMed  |  

Romer-Oberdorfer, A., W. Ortrud, V. Jutta, M. Teshome and C.M. Thomas, 2003. Contribution of the length of the HN protein and the sequence of the F protein cleavage site to Newcastle disease virus pathogenicity. J. Gen. Virol., 84: 3121-3129.
CrossRef  |  PubMed  |  Direct Link  |  

Rudensky, A.Y., M. Maric, S. Eastman, L. Shoemaker, P.C. DeRoos and J.S. Blum, 1994. Intracellular assembly and transport of endogenous peptide-MHC class II complexes. Immunity, 1: 585-594.
CrossRef  |  

Schnitzler, D., F. Bernstein, H. Muller and H. Becht, 1993. The genetic basis for the antigenicity of the VP2 protein of the infectious bursal disease virus. J. Gen. Virol., 74: 1563-1571.
PubMed  |  

Vakharia, V.N., D.B. Snyder, D. Lutticken, S.A. Mengel-Whereat, P.K. Savage, G.H. Edwards and M.A. Goodwin, 1994. Active and passive protection against variant and classic infectious bursal disease virus strains induced by baculovirus-expressed structural proteins. Vaccine, 12: 452-456.
CrossRef  |  

Vogt, A.B., L.J. Stern, C. Amshoff, B. Dobberstein, G.J. Hammerling and H. Kropshofer, 1995. Interference of distinct invariant chain regions with superantigen contact area and antigenic peptide binding groove of HLA-DR. J. Immunol., 155: 4757-4765.
Direct Link  |  

Wang, X.N., G.P. Zhang, J.Y. Zhou, C.H. Feng and Y.Y. Yang et al., 2005. Identification of neutralizing epitopes on the VP2 protein of infectious bursal disease virus by phage-displayed heptapeptide library screening and synthetic peptide mapping. Viral Immunol., 18: 549-557.
CrossRef  |  

Xu, F.Z., H. Ye, J.J. Wang and W.Y. Yu, 2008. The effect of site-directed mutagenesis of the ambient amino acids of leucine-based sorting motifs on the localization of chicken invariant Chain. Poult. Sci., 87: 1980-1986.
CrossRef  |  

Zanetti, F.A., M.P.D.M. Zajac, O.A. Taboga and G. Calamante, 2012. Evaluation of modified vaccinia virus Ankara expressing VP2 protein of infectious bursal disease virus as an immunogen in chickens. J. Vet. Sci., 13: 199-201.
CrossRef  |  

Zhao, W., Z. Zhang, L. Zsak and Q. Yu, 2013. Effects of the HN gene C-terminal extensions on the Newcastle disease virus virulence. Virus Genes, 47: 498-504.
CrossRef  |